Biblio

[ Author(Desc)] Title Type Year
Filters: First Letter Of Title is G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Aarts CEM, Varga E, Webbers S, Geissler J, von Lindern M, Kuijpers TW, van den Akker E. Generation and characterization of a human iPSC line SANi006-A from a Gray Platelet Syndrome patient. Stem Cell Res. 2021;55:102443.
Aarts CEM, Varga E, Webbers S, Geissler J, von Lindern M, Kuijpers TW, van den Akker E. Generation and characterization of a human iPSC line SANi007-A from a patient with a heterozygous dominant mutation in ELANE. Stem Cell Res. 2021;55:102440.
Aarts CEM, Karampini E, Wüst T, Webbers S, Varga E, Geissler J, Voorberg J, von Lindern M, Bierings R, van den Akker E, et al. Generation and characterization of a control and patient-derived human iPSC line containing the Hermansky Pudlak type 2 (HPS2) associated heterozygous compound mutation in AP3B1. Stem Cell Res. 2021;54:102444.
Aarts CEM, Varga E, Webbers S, Geissler J, von Lindern M, Kuijpers TW, van den Akker E. Generation and characterization of a human iPSC line SANi008-A from a Chédiak-Higashi Syndrome patient. Stem Cell Res. 2021;55:102442.
Ababneh NA, Barham R, Al-Kurdi B, Ali D, Sharar N, Hadidi SAl, Alatoom RM, Zalloum S, Gharandouq MH, Makahleh L, et al. Generation of an induced pluripotent stem cell (iPSC) line (JUCTCi017-A) from a patient with limb-girdle muscular dystrophy (LGMD) due to a homozygous p.Lue287Ser fs14* mutation in the SGCB gene. Stem Cell Res. 2021;54:102358.
Ababneh NA, Barham R, Al-Kurdi B, Ali D, Hadidi SAl, Ismail MA, Muamar ASH, Abdulelah AA, Madadha A, Sallam M, et al. Generation of a human induced pluripotent stem cell (iPSC) line (JUCTCi019-A) from a patient with Charcot-Marie-Tooth disease type 2A2 (CMT2A2) due to a heterozygous missense substitution c.2119C > T (p.Arg707Trp) in MFN2 gene. Stem Cell Res. 2022;62:102786.
Abbai R, Mathiyalagan R, Markus J, Kim Y-J, Wang C, Singh P, Ahn S, Farh MEl-Agamy, Yang DChun. Green synthesis of multifunctional silver and gold nanoparticles from the oriental herbal adaptogen: Siberian ginseng. Int J Nanomedicine. 2016;11:3131-3143.
Abbasi H, Behrouzikhah M, Divbandi M, Tabaraei A, Khosravi A, Nikoo HRazavi. Genomic analysis of SARS-CoV-2 variants: diagnosis and vaccination challenges. J Biomol Struct Dyn. 2023:1-13.
Abboud CN. Granulocyte colony-stimulating factor (G-CSF) Priming Improves Haploidentical Stem Cell Transplantation in High Risk AML subsets: a new role for an old work horse. Biol Blood Marrow Transplant. 2014;20(12):1873-1874.
Abdel-Fatah TMA, Russell R, Albarakati N, Maloney DJ, Dorjsuren D, Rueda OM, Moseley P, Mohan V, Sun H, Abbotts R, et al. Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer. Mol Oncol. 2014.
Abdelrahman SA, Khattab MA, Youssef MS, Mahmoud AA. Granulocyte-colony stimulating factor ameliorates di-ethylhexyl phthalate-induced cardiac muscle injury via stem cells recruitment, Desmin protein regulation, antifibrotic and antiapoptotic mechanisms. J Mol Histol. 2023.
Abdul MMd, Ibañez DP, Zhao P, Liu H, Zhong X, Li Y, Zhang M, Li W, Li Y, Ward C, et al. Generation of an induced pluripotent stem cell line (GIBHi003-A) from a Parkinson's disease patient with mutant PINK1 (p. I368N). Stem Cell Res. 2019;41:101607.
Abdulmalik S, Ramos D, Rudraiah S, Banasavadi-Siddegowda YKumar, Kumbar SG. The glucagon-like peptide 1 receptor agonist Exendin-4 induces tenogenesis in human mesenchymal stem cells. Differentiation. 2021;120:1-9.
Abraham AA, Tisdale JF. Gene Therapy for Sickle Cell Disease - Moving from the Bench to the Bedside. Blood. 2021.
Abranches E, Spyrou S, Ludwig T. GMP Banking of Human Pluripotent Stem Cells: A US and UK perspective. Stem Cell Res. 2020;45:101805.
Adhami M, MotieGhader H, Haghdoost AAkbar, Afshar RMalekpour, Sadeghi B. Gene co-expression network approach for predicting prognostic microRNA biomarkers in different subtypes of breast cancer. Genomics. 2019.
Aerts-Kaya F, Kiliç E, Köse S, Aydin G, Cagnan I, Kuşkonmaz B, Uckan-Cetinkaya D. G-CSF treatment of healthy pediatric donors affects their hematopoietic microenvironment through changes in bone marrow plasma cytokines and stromal cells. Cytokine. 2020;139:155407.
Affolter K, Tamm M, Jahn K, Halter J, Passweg J, Hirsch HH, Stolz D. Galactomannan in the Bronchoalveolar Lavage for Diagnosing Invasive Fungal Disease. Am J Respir Crit Care Med. 2014.
Agarwal A, Cooke L, Riley C, Qi W, Mount D, Mahadevan D. Genetic and cytokine changes associated with symptomatic stages of CLL. Leuk Res. 2014.
Aghajani R, Saeidi M, Amiriani T, Marjani M, Amiriani AHossein, Tabib AAkhavan, Marjani A. Genetic polymorphisms -137 (G > C) (rs187238) and -607 (C > A) (rs1946518) and serum level of interleukin 18 in Fars ethnic groups with metabolic syndrome in Northern Iran. Arch Physiol Biochem. 2020:1-7.
Aghazadeh Y, Sarangi F, Poon F, Nkennor B, McGaugh EC, Nunes SS, M Nostro C. GP2-enriched pancreatic progenitors give rise to functional beta cells in vivo and eliminate the risk of teratoma formation. Stem Cell Reports. 2022.
Agudo J, Ruzo A, Park ESook, Sweeney R, Kana V, Wu M, Zhao Y, Egli D, Merad M, Brown BD. GFP-specific CD8 T cells enable targeted cell depletion and visualization of T-cell interactions. Nat Biotechnol. 2015.
Ahmad I, Goel D, Ghosh A, Kapoor H, Kumar D, Ramesh K, Ashley B, Deepika K, Shastry A, Faruq M. Generation of two induced pluripotent stem cell (iPSC) lines from patients with Duchenne muscular dystrophy (IGIBi006-A and IGIBi008-A) carrying exonic deletions in the dystrophin gene. Stem Cell Res. 2022;64:102927.
Ahmad I, Kapoor H, Srivastava AKumar, Faruq M. Generation and characterization of two human iPSC lines, IGIBi014-A and IGIBi015-A, from Friedreich's ataxia (FRDA) patients with pathogenic (GAA/TTC)n repeat expansion in first intron of the Frataxin (FXN) gene. Stem Cell Res. 2023;74:103289.
Ahmed N, Stenvers KL. Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research. Front Oncol. 2013;3:256.

Pages